James Rosser, MD
Surgery · Lancaster, WINPI 1851373807
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Cook Incorporated at 45.5% of the total. Reporting peaked in 2019 at $42,856 and has fallen 100.0% since, to $12 in 2022. Among surgery clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 57 payments — averaging $1445.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$38K
- Boston Scientific$35K
- KARL Storz Endoscopy-america$5K
- Cook Medical LLC$4K
- Heron Therapeutics, Inc.$2K
- Covidien LP$108
- plus $12 from 1 others
What the payments were for
- Consulting fees$39,57548%
- Speaking & faculty fees$31,30038%
- Grants$5,0006%
- Travel & lodging$5,3266%
- Food & beverage$1,1791%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 16 | $37,508 |
| Boston Scientific | 17 | $34,513 |
| KARL Storz Endoscopy-america | 1 | $5,000 |
| Cook Medical LLC | 19 | $3,550 |
| Heron Therapeutics, Inc. | 2 | $1,690 |
| Covidien LP | 1 | $108 |
| BD | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cook Medical CBDE$38,952
- SPYGLASS$22,330
- GENERAL - THERAPIES$12,000
- N/A$5,000
- HTX-011$1,690
- Cook Medical Surgery$1,559
How this compares
$82,381 in reported general payments places this provider in the 95th percentile of 499 surgery providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 316 | $4,477 |
| Sucralfate | 278 | $4,089 |
| Famotidine | 82 | $806 |
| Ursodiol | 15 | $739 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 53 | $730 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 50 | $727 |
| Pantoprazole Sodium | 16 | $202 |
Paid to pharmacies, not to this prescriber.
Other surgery in Lancaster
- Peter UllrichAppleton$18M
- Matthew GoldblattMilwaukee$594K
- Raymond GeorgenNeenah$325K
- Cynthia GeocarisGreen Bay$263K
- Rana HigginsMilwaukee$148K
- Mustafa BadruddujaKenosha$134K
- Geoffrey RoelantEau Claire$118K
- Peter JanuChilton$113K
- Manfred ChiangBrookfield$110K
- Ryan JuzaMadison$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.